logoTry Persana

PostEra - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about PostEra including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

PostEra company logo

Medicinal Chemistry powered by Machine Learning

PostEra is building a modern biopharma using machine learning to accelerate drug discovery and develop new cures for diseases.

HeadquartersBoston, Massachusetts, United States
Team size10-50
Founded2019

What is PostEra? - Company Overview & Details

PostEra is PostEra is building a modern biopharma using machine learning to accelerate drug discovery and develop new cures for diseases. Founded in 2019, the company is headquartered in Boston, Massachusetts, United States.

Who Founded PostEra?

PostEra was founded by Aaron Morris.

Who are the Key Executives at PostEra? - Leadership Team

PostEra is led by experienced executives in key positions:

Chief Executive Officer (CEO) of PostEra

Aaron MorrisCEO

About Aaron Morris - CEO of PostEra

Aaron Morris serves as the Chief Executive Officer of PostEra, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

PostEra Company Details & Key Information

Where is PostEra located?

PostEra is headquartered in Boston, Massachusetts, United States.

How many employees does PostEra have?

PostEra has 10-50 employees.

When was PostEra founded?

PostEra was founded in 2019.

PostEra Official Website

How much funding has PostEra raised?

PostEra has raised $26 Million across 4 funding rounds. The most recent funding was completed on 2022-06-18.

Funding Overview

PostEra has raised a total of $26 Million from top investors, including a significant partnership to prevent pandemics.

$26 Million
Total Funding Raised
4
Funding Rounds
2022-06-18
Latest Round

PostEra Funding History

Grant
2021-05-20
$141K

Who are the key investors in PostEra?

PostEra is backed by 1 key investors including National Institutes of Health. These investors focus on healthcare, biotechnology sectors.

PostEra Investor Overview

1
Key Investors
2
Focus Areas
0
Notable Investments

Complete List of PostEra Investors

National Institutes of Health

A major funding body supporting health-related research.

Investment Focus
healthcare
biotechnology

What sectors do PostEra investors focus on?

The investors backing PostEra primarily focus on healthcare, biotechnology sectors.

healthcare
biotechnology

Featured Investor: National Institutes of Health

National Institutes of Health

A major funding body supporting health-related research.

Notable Investments:

What are PostEra's future plans?

PostEra PostEra aims to continue advancing partnerships and innovations in drug discovery.

PostEra Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does PostEra face?

PostEra has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for PostEra

1

Maintaining competitive edge in technology

2

Navigating partnership complexities

What opportunities does PostEra have?

PostEra has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for PostEra

1

Expanding into global markets

2

Advancing AI in drug discovery

PostEra Strategic Position Summary

Key Focus Areas

PostEra is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about PostEra?

PostEra has 2 recent news updates covering key business developments and market activities.

PostEra News Overview

2
Recent Articles
Active
Media Coverage
2023-04-24
Latest Update

What is PostEra in the news for?

PostEra is currently featured in news for Pfizer Inc partnered with PostEra on Dec 1st '20. and other significant business developments.

Recent News Articles About PostEra

Article 1
2023-04-24

Pfizer Inc partnered with PostEra on Dec 1st '20.

Pfizer partnered with PostEra to accelerate small molecule drug discovery using generative chemistry technologies.

globenewswire.com
Read News
Article 2
2023-06-02

PostEra is developing cures for diseases, faster.

PostEra is using machine learning to accelerate drug discovery efforts to bring more cures to patients.

ai-jobs.net
Read News

PostEra FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about PostEra including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

PostEra Questions & Answers - Company Information

Q1

What is PostEra?

PostEra is building a modern biopharma using machine learning to accelerate drug discovery and develop new cures for diseases.

Q2

Who founded PostEra?

PostEra was founded by Aaron Morris.

Q3

Who is the CEO of PostEra?

The CEO of PostEra is Aaron Morris. You can find more information about them on their LinkedIn profile.

Q4

How much funding has PostEra raised?

PostEra has raised a total of $$26 Million across 4 funding rounds. The most recent funding was completed on 2022-06-18.

Q5

Who are the investors in PostEra?

PostEra's key investors include National Institutes of Health.

Q6

Where is PostEra headquartered?

PostEra is headquartered in Boston, Massachusetts, United States.

Q7

When was PostEra founded?

PostEra was founded in 2019.

Q8

How many employees does PostEra have?

PostEra has 10-50 employees.

Q9

What is PostEra's official website?

You can visit PostEra's official website at http://www.postera.ai.

Q10

What was PostEra's latest funding round?

PostEra's latest funding round was a Grant round of $$141K completed on 2021-05-20.

Q11

Who is founder?

Aaron Morris

Q12

What does the company do?

PostEra is building a modern biopharma using machine learning to accelerate drug discovery and develop new cures for diseases.

Q13

How much funding?

$26 Million

Q14

Latest funding date?

2021-05-20

Q15

Who are the investors?

National Institutes of Health

Q16

What are the challenges?

Maintaining competitive edge in technology Navigating partnership complexities

Q17

What are the opportunities?

Expanding into global markets Advancing AI in drug discovery

Q18

Latest news?

Pfizer partnered with PostEra to accelerate small molecule drug discovery using generative chemistry technologies. PostEra is using machine learning to accelerate drug discovery efforts to bring more cures to patients.

More Information About PostEra

For additional details about PostEra, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.